These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 343976

  • 1. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B, De Colibus V, Napolitano L, Aliperta A, Caldarelli G, Abignente F.
    Clin Ter; 1977 Dec 31; 83(6):625-9. PubMed ID: 343976
    [No Abstract] [Full Text] [Related]

  • 2. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M, Portmann B.
    Schweiz Med Wochenschr; 1969 Feb 08; 99(6):178-82. PubMed ID: 5781367
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May 08; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S, Reynolds TB.
    Gastroenterology; 1970 Dec 10; 59(6):833-41. PubMed ID: 5486268
    [No Abstract] [Full Text] [Related]

  • 9. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G, Lazzaroni M, Petrillo M.
    Nouv Presse Med; 1975 Apr 05; 4(14):1043. PubMed ID: 1093119
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P.
    Schweiz Med Wochenschr; 1971 Mar 20; 101(11):398-401. PubMed ID: 5558553
    [No Abstract] [Full Text] [Related]

  • 11. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V, Porcellati C, Corea L, Todisco T.
    Minerva Nefrol; 1968 Mar 20; 15(4):258-60. PubMed ID: 5745815
    [No Abstract] [Full Text] [Related]

  • 12. [Modern diuretic therapy in chronic liver diseases].
    Schnack H.
    Wien Med Wochenschr; 1965 Sep 25; 115(39):796-801. PubMed ID: 5325222
    [No Abstract] [Full Text] [Related]

  • 13. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

  • 14. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A, Meloni G.
    Minerva Med; 1967 Nov 07; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract] [Full Text] [Related]

  • 15. Bumetanide in the treatment of hepatic ascites.
    Ring-Larsen H.
    Postgrad Med J; 1975 Nov 07; 51 Suppl 6():77-81. PubMed ID: 1105536
    [No Abstract] [Full Text] [Related]

  • 16. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R, Cavatorta F, Queirolo C.
    G Clin Med; 1983 Nov 07; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract] [Full Text] [Related]

  • 17. [Furosemide-amiloride combination in the treatment of ascitic-edema in patients with hepatic cirrhosis].
    Uribe M, Rojas S, Casián C, Sierra JG, Moreno J, Lewis H, Guevara L.
    Rev Gastroenterol Mex; 1980 Nov 07; 45(2):63-8. PubMed ID: 7403764
    [Abstract] [Full Text] [Related]

  • 18. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP, Sawinsky I, Juhos E.
    Int J Clin Pharmacol Biopharm; 1976 Oct 07; 14(3):163-7. PubMed ID: 1002353
    [Abstract] [Full Text] [Related]

  • 19. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W.
    Internist (Berl); 1966 Jan 07; 7(1):48-54. PubMed ID: 4861685
    [No Abstract] [Full Text] [Related]

  • 20. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar 07; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.